Instrument Inactif

Communiqués MTS Medication Technologies, Inc.

Actions

US5537731029

Equipement, fournitures et distribution médicale

Cours en clôture Nasdaq
- USD - Graphique intraday de MTS Medication Technologies, Inc.

Communiqués

19/04/16 MTS Medication Technologies : MACOM and Amphenol Support Ross Video for Industry's First 12G SDI openGear Platform PU
08/03/16 MTS Medication Technologies : MACOM Announces Industry's First CWDM4 L-PIC™ for 100G Datacenter Applications PU
19/02/16 MTS Medication Technologies : MACOM Showcases Industry's Broadest Portfolio of RF to Light Solutions for Wireless Network Infrastructure PU
11/11/15 MTS Medication Technologies : MACOM SPARTM Tiles Selected by Massachusetts Institute of Technology's Lincoln Laboratory as Testbed for the DARPA ACT Radar Development Program PU
14/09/15 MTS Medication Technologies : MACOM's 12G Chipset Selected for Marshall Electronics' New 12G-SDI Broadcast Converters PU
17/08/15 MTS Medication Technologies : MACOM Completes Divestiture of Automotive Business PU
10/08/15 MTS Medication Technologies : MACOM to Showcase Optical Portfolio Solutions at CIOE 2015 in Shenzhen, China from August 31 - September 3, 2015 PU
13/05/15 MTS Medication Technologies : MACOM Announces Fourth Generation GaN Technology PU
06/02/15 MACOM Announces Upsize and Pricing of Public Offering of Common Stock GL
02/02/15 MACOM Announces Proposed Public Offering of Common Stock GL
02/02/15 MACOM Reports Revenue of $114.9 Million With EPS $0.38 and Gross Margin of 53.7 Percent (Non-GAAP) GL
21/01/15 MACOM to Present at the Stifel Technology, Internet and Media Conference on February 10 GL
12/01/15 MACOM to Announce First Quarter Fiscal 2015 Financial Results on February 2, 2015 GL
22/12/14 MACOM to Present at the Needham Growth Conference on January 13 GL
16/12/14 MACOM Successfully Completes Acquisition of BinOptics Corporation GL
20/11/14 MACOM to Participate at the Barclays Global Technology Conference on December 9 GL
18/11/14 MACOM Reports Strong Growth; Revenue of $114.3 Million With EPS of $0.35 and Gross Margin of 54.1 Percent (non-GAAP) GL
18/11/14 MACOM Announces Definitive Agreement to Acquire BinOptics Corporation GL
21/10/14 MACOM to Announce Fourth Quarter Fiscal 2014 Financial Results on November 18, 2014 GL
24/09/14 MTS Medication Technologies : MACOM Announces Industry's Leading Up-Converter for 28 - 34 GHz Point-to-Point Radio Applications PU
11/09/14 MTS Medication Technologies : MACOM's 12G-SDI Chipset Chosen by PHABRIX to Deliver Next-Generation 4K Video Test and Measurement Solutions PU
05/09/14 MTS Medication Technologies : MACOM Announces Industry's First Four Channel CDR with Integrated High Output Voltage EML Driver for 100G Optical Modules PU
05/09/14 MTS Medication Technologies : MACOM Announces the Industry's Most Integrated 10G SFP+ Optical Module Chipset Solution PU
05/09/14 MTS Medication Technologies : MACOM Extends Industry Leading GaN Portfolio with New 15 W GaN on SiC Pulsed Power Transistor PU
14/08/14 MACOM to Participate at the Jefferies 2014 Semiconductors, Hardware & Communications Infrastructure Summit on August 27 GL
Aucun résultat pour cette recherche